CompletedNot Applicable

Different Doses of Dexmedetomidine in External Oblique Intercostal Plane Block in Splenectomy

Egypt50 participantsStarted 2024-04-20

Plain-language summary

The aim of this study is to compare the analgesic effects of different doses of dexmedetomidine as an adjuvant in external oblique intercostal plane block (EOIPB) in splenectomy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status II-III. * Scheduled for splenectomy. Exclusion Criteria: * Body mass index (BMI) ≥35 kg/m2 * History of abdominal surgery. * Infection at the injection site. * Drug abuse. * Allergic reaction to local anesthetics. * Coagulation abnormalities. * Pregnancy. * Severe cardiovascular problems. * Diabetic neuropathy.

What they're measuring

Time to the 1st rescue analgesia

Timeframe: 48 hour Postoperatively

Trial details

NCT IDNCT06363578

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-08

View on ClinicalTrials.gov More Dexmedetomidine trials